3D Bioprinting

Why Organovo Stock Continues to Drop

We’ve been writing about disruptive technologies like 3D bioprinting for the past seven years now. The promise of bioprinted human tissues is something that wall street analysts have been patiently waiting for a while now, at least when it comes to Organovo Holdings (ONVO). The company’s stock has been steadily plummeting over the years while […]

Can 3D Printing of Alternative Proteins Take Off?

Regular readers will be familiar with Gartner’s Hype Cycle for emerging technologies, which graphically represents the ups and downs that most new technologies undergo, as they move from the “that’s super cool” stage to “what’s it good for” stage to “here’s how we can actually make money” stage. We often refer to the Hype Cycle […]

Nine 3D Bioprinting Companies Making Progress

When trying to get your arms around who is doing what for any given technology, things change quickly. In our recent piece on artificial intelligence for drug discovery, we noted how the number of players in this space has exploded to more than 125 startups using machine learning to improve some aspect of the drug […]

A 3D Bioprinting Stock That’s Not Organovo

One thing we’ve noticed over the years is that the way we imagine a disruptive technology being commercialized is rarely how things actually transpire. We’re seeing that now as 3D printing business models and technologies evolve over time into something different. The same can be said for the companies that are involved in disruptive technologies where […]

BioBots is Selling a 3D Bioprinter for $10,000

In August of 2013, we wrote about a company called EnvisionTEC and their 286 pound 3D Bioprinter which was selling for under $200,000. At this price point, 3D bioprinting remains largely out of reach for most consumers who might want to play around with this new technology but don’t have that type of cash laying […]

An Organovo Article With a Negative Spin

We’ve been watching Organovo for a while now. For retail investors who want to invest in 3D bioprinting, Organovo (ONVO) is the only pure play in town. However, this doesn’t mean they have a monopoly by any means. German startup EnvisionTEC has been selling their 3D Bio-Printer commercially since 2001 at a price point under $200,000 USD. At […]

Should Organovo Investors be Worried About Insphero?

Several months ago, we published an article titled “Organs-on-Chips: An Alternative to 3D Bioprinting?” in which we speculated that 3D Bioprinting small samples of organ tissues to use for drug testing could be displaced by organs-on-chips. Organovo (NYSEMKT:ONVO), the only publicly traded 3D Bioprinting company, commands a market cap of over $500 million with just minuscule […]

Organs-on-Chips: An Alternative to 3D Bioprinting?

While 3D Printing has attracted a great deal of attention from investors because of high growth projections, 3D Bioprinting has attracted investors because of its futuristic appeal. Some companies involved in 3D Bioprinting are raising eyebrows with their lofty ambitions, like private company Modern Meadow which is looking to 3D Print leather, or publicly traded […]

3D Bioprinting with Rainbow Coral Corp

Many disruptive technologies attract the attention of investors and consequently, many companies will seek to attach themselves to these technologies. In a previous article, we highlighted 6 over-the-counter companies which quickly latched onto “nanotechnology” when it became a hot topic in 2004-2005. An investor during this time who would have would have invested $5,000 in each of […]

EnvisionTEC sells 3D Bio-Printer under 200K

In earlier articles, we discussed 3D Bio-Printing technology company Organovo. What many Organovo investors might not know is that a little known German company, EnvisionTEC, is already selling a 3D Bio-Printer which has been sold commercially since 2001 and is currently installed in many research universities, labs, and hospitals worldwide. The price is just under 200,000 USD according to this […]